First, targeting pan T-cell antigens or those frequently expressed in all healthy T-cells—such as CD3, CD5, and CD7—can lead to T-cell aplasia, rendering patients profoundly immunocompromised and at risk for life-threatening infections [52]. This evidence concerns the gene CD5 and infection.